Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)
This study is ongoing, but not recruiting participants.
Lions Eye Institute, Perth, Western Australia
Avalanche Biotechnologies, Inc.
Information provided by (Responsible Party):
Prof. P. Elizabeth Rakoczy, Lions Eye Institute, Perth, Western Australia
First received: December 14, 2011
Last updated: April 9, 2014
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||May 2017|
|Estimated Primary Completion Date:||May 2015 (Final data collection date for primary outcome measure)|